The Many Faces of FKBP51

Sinars, 2003, Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes, Proc. Natl. Acad. Sci. USA, 100, 868, 10.1073/pnas.0231020100

Wu, 2004, 3D structure of human FK506-binding protein 52: Implications for the assembly of the glucocorticoid receptor/Hsp90/immunophilin heterocomplex, Proc. Natl. Acad. Sci. USA, 101, 8348, 10.1073/pnas.0305969101

Bracher, 2013, Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge, J. Mol. Biol., 425, 4134, 10.1016/j.jmb.2013.07.041

Marz, 2013, Large FK506-binding proteins shape the pharmacology of rapamycin, Mol. Cell. Biol., 33, 1357, 10.1128/MCB.00678-12

Kozany, 2009, Fluorescent probes to characterise FK506-binding proteins, Chembiochem, 10, 1402, 10.1002/cbic.200800806

Wilson, 1995, Comparative X-ray structures of the major binding protein for the immunosuppressant FK506 (tacrolimus) in unliganded form and in complex with FK506 and rapamycin, Acta Crystallogr. D Biol. Crystallogr., 51, 511, 10.1107/S0907444994014514

Bracher, 2011, Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90, Acta Crystallogr. D Biol. Crystallogr., 67, 549, 10.1107/S0907444911013862

Gopalakrishnan, 2012, Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52, J. Med. Chem., 55, 4114, 10.1021/jm201746x

Wang, 2013, Increasing the efficiency of ligands for FK506-binding protein 51 by conformational control, J. Med. Chem., 56, 3922, 10.1021/jm400087k

Pomplun, 2018, Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins, J. Med. Chem., 61, 3660, 10.1021/acs.jmedchem.8b00137

Gaali, 2015, Selective inhibitors of the FK506-binding protein 51 by induced fit, Nat. Chem. Biol., 11, 33, 10.1038/nchembio.1699

LeMaster, 2015, Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins, J. Biol. Chem., 290, 15746, 10.1074/jbc.M115.650655

Mustafi, 2014, Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52, Biochem. J., 461, 115, 10.1042/BJ20140232

LeMaster, 2015, Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design, Curr. Mol. Pharmacol., 9, 5, 10.2174/1874467208666150519113146

Riggs, 2007, Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling, Mol. Cell. Biol., 27, 8658, 10.1128/MCB.00985-07

Kumar, 2017, Combined X-ray crystallography and computational modeling approach to investigate the Hsp90 C-terminal peptide binding to FKBP51, Sci. Rep., 7, 14288, 10.1038/s41598-017-14731-z

Scheufler, 2000, Structure of TPR domain-peptide complexes: Critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine, Cell, 101, 199, 10.1016/S0092-8674(00)80830-2

Yang, J., Roe, S.M., Cliff, M.J., Williams, M.A., Ladbury, J.E., Cohen, P.T., and Barford, D. (2005). Molecular basis for TPR domain-mediated regulation of protein phosphatase 5. EMBO J.

Blundell, K.L., Pal, M., Roe, S.M., Pearl, L.H., and Prodromou, C. (2017). The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90. PLoS ONE, 12.

Ebong, 2016, The interchange of immunophilins leads to parallel pathways and different intermediates in the assembly of Hsp90 glucocorticoid receptor complexes, Cell Discov., 2, 16002, 10.1038/celldisc.2016.2

Assimon, 2015, Specific Binding of Tetratricopeptide Repeat Proteins to Heat Shock Protein 70 (Hsp70) and Heat Shock Protein 90 (Hsp90) Is Regulated by Affinity and Phosphorylation, Biochemistry, 54, 7120, 10.1021/acs.biochem.5b00801

Budzinski, 2016, The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51, Cell Death Differ., 23, 1579, 10.1038/cdd.2016.44

Roberts, 2003, C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90, J. Biol. Chem., 278, 17388, 10.1074/jbc.M300955200

Oroz, 2018, Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex, Nat. Commun., 9, 4532, 10.1038/s41467-018-06880-0

Zannas, 2016, Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications, Neuropsychopharmacology, 41, 261, 10.1038/npp.2015.235

Matosin, 2018, Understanding the Molecular Mechanisms Underpinning Gene by Environment Interactions in Psychiatric Disorders: The FKBP5 Model, Biol. Psychiatry, 83, 821, 10.1016/j.biopsych.2018.01.021

Klengel, 2013, Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions, Nat. Neurosci., 16, 33, 10.1038/nn.3275

Pereira, 2014, FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance, Metabolism, 63, 1198, 10.1016/j.metabol.2014.05.015

Bortsov, 2013, Polymorphisms in the glucocorticoid receptor co-chaperone FKBP5 predict persistent musculoskeletal pain after traumatic stress exposure, Pain, 154, 1419, 10.1016/j.pain.2013.04.037

Linnstaedt, 2018, A Functional riboSNitch in the 3’ Untranslated Region of FKBP5 Alters MicroRNA-320a Binding Efficiency and Mediates Vulnerability to Chronic Post-Traumatic Pain, J. Neurosci., 38, 8407, 10.1523/JNEUROSCI.3458-17.2018

Menke, 2012, Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients, Neuropsychopharmacology, 37, 1455, 10.1038/npp.2011.331

Baida, 2018, Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy, Oncotarget, 9, 34772, 10.18632/oncotarget.26194

Hartmann, 2015, Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties, J. Neurosci., 35, 9007, 10.1523/JNEUROSCI.4024-14.2015

Scharf, S.H., Liebl, C., Binder, E.B., Schmidt, M.V., and Muller, M.B. (2011). Expression and regulation of the FKBP5 gene in the adult mouse brain. PLoS ONE, 6.

Maiaru, 2018, The stress regulator FKBP51: A novel and promising druggable target for the treatment of persistent pain states across sexes, Pain, 159, 1224, 10.1097/j.pain.0000000000001204

O’Leary, J.C., Dharia, S., Blair, L.J., Brady, S., Johnson, A.G., Peters, M., Cheung-Flynn, J., Cox, M.B., de Erausquin, G., and Weeber, E.J. (2011). A new anti-depressive strategy for the elderly: Ablation of FKBP5/FKBP51. PLoS ONE, 6.

Touma, 2011, FK506 binding protein 5 shapes stress responsiveness: Modulation of neuroendocrine reactivity and coping behavior, Biol. Psychiatry, 70, 928, 10.1016/j.biopsych.2011.07.023

Hartmann, 2012, The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress, Neuropharmacology, 62, 332, 10.1016/j.neuropharm.2011.07.041

Albu, 2014, Deficiency of FK506-binding protein (FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice, J. Sleep Res., 23, 176, 10.1111/jsr.12112

Stechschulte, 2016, FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone, Endocrinology, 157, 3888, 10.1210/en.2015-1996

Balsevich, 2017, Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function, Nat. Commun., 8, 1725, 10.1038/s41467-017-01783-y

Maiaru, 2016, The stress regulator FKBP51 drives chronic pain by modul[ating spinal glucocorticoid signaling, Sci. Transl. Med., 8, 325ra319, 10.1126/scitranslmed.aab3376

Kastle, 2018, FKBP51 modulates steroid sensitivity and NFκB signalling: A novel anti-inflammatory drug target, Eur. J. Immunol., 48, 1904, 10.1002/eji.201847699

Sabbagh, J.J., O’Leary, J.C., Blair, L.J., Klengel, T., Nordhues, B.A., Fontaine, S.N., Binder, E.B., and Dickey, C.A. (2014). Age-associated epigenetic upregulation of the FKBP5 gene selectively impairs stress resiliency. PLoS ONE, 9.

Pohlmann, 2018, Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs, Front. Behav. Neurosci., 12, 262, 10.3389/fnbeh.2018.00262

Schopf, 2017, The HSP90 chaperone machinery, Nat. Rev. Mol. Cell Biol., 18, 345, 10.1038/nrm.2017.20

Smith, 1990, Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins, J. Biol. Chem., 265, 3996, 10.1016/S0021-9258(19)39693-0

Smith, 1993, FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts, J. Biol. Chem., 268, 24270, 10.1016/S0021-9258(20)80520-1

Chen, 1998, Differential interactions of p23 and the TPR-containing proteins Hop, Cyp40, FKBP52 and FKBP51 with Hsp90 mutants, Cell Stress Chaperones, 3, 118, 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2

Smith, 1995, Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent, Mol. Cell. Biol., 15, 6804, 10.1128/MCB.15.12.6804

Mayer, 2015, Hsp90: Breaking the symmetry, Mol. Cell, 58, 8, 10.1016/j.molcel.2015.02.022

Rohl, 2013, The chaperone Hsp90: Changing partners for demanding clients, Trends Biochem. Sci., 38, 253, 10.1016/j.tibs.2013.02.003

Schülke, J.P., Wochnik, G.M., Lang-Rollin, I., Gassen, N.C., Knapp, R.T., Berning, B., Yassouridis, A., and Rein, T. (2010). Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors. PLoS ONE, 5.

Pirkl, 2001, Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40, J. Mol. Biol., 308, 795, 10.1006/jmbi.2001.4595

Taipale, 2014, A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways, Cell, 158, 434, 10.1016/j.cell.2014.05.039

Li, 2011, Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle, Nat. Struct. Mol. Biol., 18, 61, 10.1038/nsmb.1965

Echeverria, 2010, Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility, Biochim. Biophys. Acta, 1803, 641, 10.1016/j.bbamcr.2009.11.012

Barent, 1998, Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes, Mol. Endocrinol., 12, 342, 10.1210/mend.12.3.0075

Baughman, 1997, Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition, Biochem. Biophys. Res. Commun., 232, 437, 10.1006/bbrc.1997.6307

Reynolds, 1998, Glucocorticoid-resistant B-lymphoblast cell line derived from the Bolivian squirrel monkey (Saimiri boliviensis boliviensis), Lab. Anim. Sci., 48, 364

Wan, 2002, Identification of genes differentially regulated by glucocorticoids and progestins using a Cre/loxP-mediated retroviral promoter-trapping strategy, J. Mol. Endocrinol., 28, 177, 10.1677/jme.0.0280177

Vermeer, 2003, Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability, J. Clin. Endocrinol. Metab., 88, 277, 10.1210/jc.2002-020354

Kester, 1997, Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation, J. Biol. Chem., 272, 16637, 10.1074/jbc.272.26.16637

Hubler, 2003, The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness, Endocrinology, 144, 2380, 10.1210/en.2003-0092

Hubler, 2004, Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids, Cell Stress Chaperones, 9, 243, 10.1379/CSC-32R.1

Amler, 2000, Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1, Cancer Res., 60, 6134

Mousses, 2001, Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling, Oncogene, 20, 6718, 10.1038/sj.onc.1204889

Zhu, 2001, Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP, Carcinogenesis, 22, 1399, 10.1093/carcin/22.9.1399

Paakinaho, 2010, Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions, Mol. Endocrinol., 24, 511, 10.1210/me.2009-0443

Riggs, 2003, The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo, EMBO J., 22, 1158, 10.1093/emboj/cdg108

Wochnik, 2005, FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells, J. Biol. Chem., 280, 4609, 10.1074/jbc.M407498200

Stechschulte, 2014, FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ, Mol. Endocrinol., 28, 1265, 10.1210/me.2014-1022

Sabbagh, 2018, Targeting the FKBP51/GR/Hsp90 Complex to Identify Functionally Relevant Treatments for Depression and PTSD, ACS Chem. Biol., 13, 2288, 10.1021/acschembio.8b00454

Ni, 2010, FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells, Mol. Cell. Biol., 30, 1243, 10.1128/MCB.01891-08

Periyasamy, 2010, FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A, Oncogene, 29, 1691, 10.1038/onc.2009.458

Caratti, 2015, Glucocorticoid receptor function in health and disease, Clin. Endocrinol., 83, 441, 10.1111/cen.12728

Pei, 2009, FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt, Cancer Cell, 16, 259, 10.1016/j.ccr.2009.07.016

Luo, 2017, USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling, EMBO J., 36, 1434, 10.15252/embj.201695669

Gassen, N.C., Hartmann, J., Zschocke, J., Stepan, J., Hafner, K., Zellner, A., Kirmeier, T., Kollmannsberger, L., Wagner, K.V., and Dedic, N. (2014). Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: Evidence in cells, mice, and humans. PLoS Med., 11.

Yu, 2017, Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7, Cell Rep., 18, 1229, 10.1016/j.celrep.2017.01.009

Fabian, A.K., Marz, A., Neimanis, S., Biondi, R.M., Kozany, C., and Hausch, F. (2013). InterAKTions with FKBPs–mutational and pharmacological exploration. PLoS ONE, 8.

Gassen, 2016, FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications, Mol. Psychiatry, 21, 277, 10.1038/mp.2015.38

Jiang, 2008, FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-κB signaling pathway, Neoplasia, 10, 235, 10.1593/neo.07929

Romano, 2010, Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells, Cell Death Differ., 17, 145, 10.1038/cdd.2009.115

Romano, 2015, FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma, Nucleic Acids Res., 43, 6983, 10.1093/nar/gkv615

Srivastava, 2015, Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis, Br. J. Cancer, 112, 1772, 10.1038/bjc.2015.154

Romano, 2004, Rapamycin inhibits doxorubicin-induced NF-κB/Rel nuclear activity and enhances the apoptosis of melanoma cells, Eur. J. Cancer, 40, 2829, 10.1016/j.ejca.2004.08.017

Zhang, 2017, 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology, Cell, 168, 37, 10.1016/j.cell.2016.12.012

Cildir, 2016, Noncanonical NF-κB Signaling in Health and Disease, Trends Mol. Med., 22, 414, 10.1016/j.molmed.2016.03.002

Mitchell, 2016, Signaling via the NFκB system, Wiley Interdiscip. Rev. Syst. Biol. Med., 8, 227, 10.1002/wsbm.1331

Akiyama, T., Shiraishi, T., Qin, J., Konno, H., Akiyama, N., Shinzawa, M., Miyauchi, M., Takizawa, N., Yanai, H., and Ohashi, H. (2014). Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN. PLoS ONE, 9.

Bouwmeester, 2004, A physical and functional map of the human TNF-α/NF-κ B signal transduction pathway, Nat. Cell Biol., 6, 97, 10.1038/ncb1086

Erlejman, 2014, NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: A role for peptidyl-prolyl isomerase activity, J. Biol. Chem., 289, 26263, 10.1074/jbc.M114.582882

Hinz, 2007, Signal responsiveness of IκB kinases is determined by Cdc37-assisted transient interaction with Hsp90, J. Biol. Chem., 282, 32311, 10.1074/jbc.M705785200

Gassen, 2015, Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine, Sci. Signal., 8, ra119, 10.1126/scisignal.aac7695

Jirawatnotai, 2014, The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis, Cell Cycle, 13, 2889, 10.4161/15384101.2014.946850

Jinwal, 2010, The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules, J. Neurosci., 30, 591, 10.1523/JNEUROSCI.4815-09.2010

Quinta, 2010, Subcellular rearrangement of hsp90-binding immunophilins accompanies neuronal differentiation and neurite outgrowth, J. Neurochem., 115, 716, 10.1111/j.1471-4159.2010.06970.x

Gaali, 2016, Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51, J. Med. Chem., 59, 2410, 10.1021/acs.jmedchem.5b01355

Pomplun, 2015, Rational design and asymmetric synthesis of potent and neurotrophic ligands for FK506-binding proteins (FKBPs), Angew. Chem. Int. Ed., 54, 345, 10.1002/anie.201408776

Hamilton, 2018, Serine/threonine phosphatase 5 (PP5C/PPP5C) regulates the ISOC channel through a PP5C-FKBP51 axis, Pulm. Circ., 8, 2045893217753156, 10.1177/2045893217753156

Kadeba, 2013, Regulation of store-operated calcium entry by FK506-binding immunophilins, Cell Calcium, 53, 275, 10.1016/j.ceca.2012.12.008

Sinkins, 2004, Association of immunophilins with mammalian TRPC channels, J. Biol. Chem., 279, 34521, 10.1074/jbc.M401156200

Lopez, 2013, Immunophilins are involved in the altered platelet aggregation observed in patients with type 2 diabetes mellitus, Curr. Med. Chem., 20, 1912, 10.2174/0929867311320140008

Lopez, 2013, FKBP52 is involved in the regulation of SOCE channels in the human platelets and MEG 01 cells, Biochim. Biophys. Acta, 1833, 652, 10.1016/j.bbamcr.2012.11.029

Lopez, 2015, FKBP25 and FKBP38 regulate non-capacitative calcium entry through TRPC6, Biochim. Biophys. Acta, 1853, 2684, 10.1016/j.bbamcr.2015.07.023

Chambraud, 1996, FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin, J. Biol. Chem., 271, 32923, 10.1074/jbc.271.51.32923

Brouillard, 2002, Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”), Am. J. Hum. Genet., 70, 866, 10.1086/339492

Brouillard, 2013, Genotypes and phenotypes of 162 families with a glomulin mutation, Mol. Syndromol., 4, 157, 10.1159/000348675

Brouillard, 2005, Four common glomulin mutations cause two thirds of glomuvenous malformations (“familial glomangiomas”): Evidence for a founder effect, J. Med. Genet., 42, e13, 10.1136/jmg.2004.024174

Neye, 2001, Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52, Regul. Pept., 97, 147, 10.1016/S0167-0115(00)00206-8

Martinez, 2013, The co-chaperones FKBP4/5 control Argonaute2 expression and facilitate RISC assembly, RNA, 19, 1583, 10.1261/rna.040790.113

Gopalakrishnan, 2012, Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52, J. Med. Chem., 55, 4123, 10.1021/jm201747c

Bischoff, 2014, Stereoselective construction of the 5-hydroxy diazabicyclo[4.3.1]decane-2-one scaffold, a privileged motif for FK506-binding proteins, Org. Lett., 16, 5254, 10.1021/ol5023195

Feng, 2015, Structure-Affinity Relationship Analysis of Selective FKBP51 Ligands, J. Med. Chem., 58, 7796, 10.1021/acs.jmedchem.5b00785

Sidibeh, 2018, FKBP5 expression in human adipose tissue: Potential role in glucose and lipid metabolism, adipogenesis and type 2 diabetes, Endocrine, 62, 116, 10.1007/s12020-018-1674-5